Buy GHRP-2 (5mg x 10) and Mod GRF 1-29 (CJC-1295 no DAC) (5mg x 10) – USA & Europe

1. What is the GHRP-2 and Mod GRF 1-29 combination

GHRP-2 and Mod GRF 1-29 are synthetic peptides that synergistically stimulate growth hormone (GH) secretion through different mechanisms:

• GHRP-2 activates ghrelin receptors (growth hormone secretagogue receptors) in the pituitary gland, increasing the frequency and amplitude of GH pulses and stimulating appetite.

• Mod GRF 1-29 (also called CJC-1295 no DAC) is a peptide analog of growth hormone releasing hormone (GHRH) that binds to GHRH receptors in the pituitary, inducing natural pulsatile GH secretion.

Together, they can induce a significant increase in GH secretion, resulting in enhanced IGF-1 levels, improved muscle growth, fat metabolism, tissue repair, immune function, and anti-aging benefits.

2. Product contents

Ten vials each of 5mg pharmaceutical-grade GHRP-2 and Mod GRF 1-29 peptides, designed for subcutaneous injection.

3. Suitable for

Adults seeking increased lean muscle mass, accelerated fat loss, enhanced recovery from physical activity or injury, improved sleep quality, bone health, and overall regenerative support.

4. Before use

Consult a healthcare professional to determine dosing, monitor health, and check for contraindications such as pregnancy, breastfeeding, or hormone-sensitive conditions.

5. Contraindications

Avoid if pregnant, breastfeeding, or diagnosed with hormone-dependent cancers.

6. Interactions

No significant drug or food interactions known; best results with healthy lifestyle habits.

7. Overdose

Discontinue use and seek medical advice if adverse effects occur.

8. Monitoring

Regular monitoring of serum GH, IGF-1, and metabolic parameters recommended.

9. Prescription requirements

Typically prescription-based; use under medical supervision.

10. Legal status

Varies by jurisdiction; generally prescription-required for clinical or research use.

11. Safety

Generally well tolerated; side effects may include injection site irritation, increased appetite (mainly GHRP-2), headaches, or dizziness.

12. Medical conditions

Consult healthcare provider if chronic diseases exist.

13. Allergy considerations

Avoid if allergic to peptides or formulation ingredients.

14. Medication interactions

Inform healthcare providers about all medications.

15. Pregnancy and breastfeeding

Use only with physician guidance.

16. Administration

Administer via subcutaneous injection, usually once or twice daily, often before sleep or workouts.

17. Best use

Maintain consistent dosing with proper diet, hydration, and exercise.

18. Effectiveness

Demonstrated induction of GH and IGF-1 secretion supporting muscle growth, fat loss, recovery, and anti-aging.

19. Side effects

Possibility of injection site pain, mild headaches, increased hunger, and transient dizziness.

20. Severe side effects

Discontinue and seek urgent medical care.

21. Alcohol

Limit consumption to support therapy effectiveness.

22. Missed dose

Apply when remembered, without doubling dose.

23. Duration

Commonly cycled 4-12 weeks; follow medical advice.

24. After stopping

GH and IGF-1 levels normalize; benefits fade.

25. Withdrawal symptoms

None reported.

26. Storage

Store refrigerated at 2-8°C, protect from light.

27. Alternatives

Other GH secretagogues include GHRP-6, Ipamorelin, Hexarelin, and CJC-1295 DAC.